Bruker Co. to Post FY2025 Earnings of $3.07 Per Share, Zacks Research Forecasts (NASDAQ:BRKR)

Bruker Co. (NASDAQ:BRKR) – Analysts at Zacks Research lowered their FY2025 earnings estimates for Bruker in a research report issued to clients and investors on Wednesday, September 18th. Zacks Research analyst R. Department now expects that the medical research company will earn $3.07 per share for the year, down from their previous forecast of $3.09. The consensus estimate for Bruker’s current full-year earnings is $2.61 per share. Zacks Research also issued estimates for Bruker’s FY2026 earnings at $3.64 EPS.

A number of other analysts have also recently weighed in on BRKR. Citigroup reduced their price target on Bruker from $95.00 to $80.00 and set a “buy” rating for the company in a research report on Wednesday, July 10th. The Goldman Sachs Group cut their price objective on Bruker from $72.00 to $60.00 and set a “sell” rating for the company in a research report on Tuesday, July 9th. TD Cowen cut their price objective on Bruker from $74.00 to $72.00 and set a “hold” rating for the company in a research report on Wednesday, August 7th. Wells Fargo & Company began coverage on Bruker in a research report on Tuesday, August 27th. They set an “overweight” rating and a $78.00 price objective for the company. Finally, Jefferies Financial Group began coverage on Bruker in a research report on Monday, June 3rd. They set a “buy” rating and a $85.00 price objective for the company. One analyst has rated the stock with a sell rating, three have issued a hold rating and seven have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $81.40.

Bruker Price Performance

Shares of NASDAQ:BRKR opened at $67.54 on Friday. Bruker has a fifty-two week low of $53.79 and a fifty-two week high of $94.86. The business has a 50-day moving average of $64.51 and a two-hundred day moving average of $73.04. The stock has a market capitalization of $9.82 billion, a P/E ratio of 24.56, a P/E/G ratio of 2.31 and a beta of 1.18. The company has a debt-to-equity ratio of 1.18, a current ratio of 1.65 and a quick ratio of 0.75.

Bruker (NASDAQ:BRKR) last announced its quarterly earnings results on Tuesday, August 6th. The medical research company reported $0.52 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.52. Bruker had a return on equity of 24.92% and a net margin of 11.29%. The company had revenue of $800.70 million during the quarter, compared to analysts’ expectations of $799.44 million. During the same quarter in the previous year, the firm earned $0.50 earnings per share. The business’s quarterly revenue was up 17.4% compared to the same quarter last year.

Institutional Investors Weigh In On Bruker

Several large investors have recently modified their holdings of the stock. Sanctuary Advisors LLC bought a new stake in shares of Bruker in the 2nd quarter valued at approximately $296,000. Gordian Capital Singapore Pte Ltd bought a new stake in shares of Bruker in the 2nd quarter valued at approximately $52,000. Maven Securities LTD grew its stake in shares of Bruker by 400.0% in the 2nd quarter. Maven Securities LTD now owns 20,000 shares of the medical research company’s stock valued at $1,276,000 after purchasing an additional 16,000 shares during the period. Aristides Capital LLC bought a new stake in shares of Bruker in the 2nd quarter valued at approximately $222,000. Finally, Cetera Investment Advisers grew its stake in shares of Bruker by 2.4% in the 2nd quarter. Cetera Investment Advisers now owns 33,936 shares of the medical research company’s stock valued at $2,165,000 after purchasing an additional 805 shares during the period. 79.52% of the stock is currently owned by institutional investors.

Bruker Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, September 16th. Shareholders of record on Monday, September 2nd were issued a $0.05 dividend. The ex-dividend date was Friday, August 30th. This represents a $0.20 annualized dividend and a yield of 0.30%. Bruker’s dividend payout ratio (DPR) is 7.27%.

Bruker Company Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.